Taysha Gene Therapies, Inc. (TSHA) Form 424B5 — Jun 24, 2026
Taysha Gene Therapies, Inc. filed a preliminary prospectus supplement for a public offering of $200 million in shares of common stock and pre-funded warrants. The company's common stock last traded at $6.86 per share on June 23, 2026. As of March 31, 2026, the company had 287,276,885 shares outstanding and cash and cash equivalents of $276.6 million.
Key figures
- Cash Position
- $276.6 million
- Deal Value Usd
- $200,000,000
- Offering Price
- 0
- Shares Outstanding
- 287276885
Price after filing
1 day: -10.5%7 days: -4.2%30 days: -16.0%
Close on the filing date to close N calendar days later (from $6.94). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.